Search
25/11/2025
Difficulties on the access to innovative targeted therapies for lung cancer in Spain
Calvo V., Camps C., Carcereny E., Cobo M., Dómine M., García Campelo M.R., González Larriba J.L., Guirado M., Hernando-Trancho F., Massutí B., Nadal E., Rodríguez-Abreu D., Sánchez A., Sullivan I.G., Provencio M.. Difficulties on the access to innovative targeted therapies for lung cancer in Spain. Clinical & Translational Oncology. ; DOI:10.1007/s12094-023-03303-5. PMID:37651020. IF:(Q/D).
01/09/2025
Flaws and weaknesses in estimating the budget impact of lung cancer screening in Spain
Rosell, A, Estrada, O, López-Seguí, F, Vicente-Gómez, JA, Robledinos-Antón, N, Seijo, LM, Trujillog, JC. Flaws and weaknesses in estimating the budget impact of lung cancer screening in Spain. Gaceta Sanitaria. 2025; 39DOI:10.1016/j.gaceta.2025.102528. PMID:41016098. IF:1.500(Q3/7D).
17/11/2025
Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial
Lozano-Borbalas, A, Jordi-Ollero, O, Marruecos, J, Farre, N, Planas, I, Toledo, MD, Mesia, R, Navarro-Martin, A. Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1679589. PMID:41333216. IF:3.300(Q2/4D).
01/01/2023
Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.
Czerwinska-Jelonkiewicz K, Wood A, Bohm A, Kwasiborski P, Oleksiak A, Ryczek R, Grand J, Tavazzi G, Sionis A, Stepinska J. Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.. Cardiology Journal. 2023; 30(6)DOI:10.5603/CJ.a2021.0173. PMID:34967939. IF:2.500(Q2/5D).